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Evolutionary clade affects 
resistance of Clostridium difficile 
spores to Cold Atmospheric Plasma
Mairéad Connor1, Padrig B. Flynn2,3, Derek J. Fairley4, Nikki Marks1, Panagiotis Manesiotis5, 
William G. Graham3, Brendan F. Gilmore2 & John W. McGrath1
Clostridium difficile is a spore forming bacterium and the leading cause of colitis and antibiotic 
associated diarrhoea in the developed world. Spores produced by C. difficile are robust and can remain 
viable for months, leading to prolonged healthcare-associated outbreaks with high mortality. Exposure 
of C. difficile spores to a novel, non-thermal atmospheric pressure gas plasma was assessed. Factors 
affecting sporicidal efficacy, including percentage of oxygen in the helium carrier gas admixture, 
and the effect on spores from different strains representing the five evolutionary C. difficile clades 
was investigated. Strains from different clades displayed varying resistance to cold plasma. Strain 
R20291, representing the globally epidemic ribotype 027 type, was the most resistant. However all 
tested strains displayed a ~3 log reduction in viable spore counts after plasma treatment for 5 minutes. 
Inactivation of a ribotype 078 strain, the most prevalent clinical type seen in Northern Ireland, was 
further assessed with respect to surface decontamination, pH, and hydrogen peroxide concentration. 
Environmental factors affected plasma activity, with dry spores without the presence of organic 
matter being most susceptible. This study demonstrates that cold atmospheric plasma can effectively 
inactivate C. difficile spores, and highlights factors that can affect sporicidal activity.
Clostridium difficile is a Gram positive, spore forming, anaerobic bacterium and the leading cause of colitis and 
antibiotic associated diarrhoea in the developed world1. Spores produced by C. difficile are extremely robust 
and can remain viable for months, even in very harsh conditions such as high temperatures2 and biocidal chal-
lenge3. Their environmental stability and resistance allow them to persist until conditions become favourable for 
germination, for example, in the human gut. C. difficile spores have been found to remain on curtains, textiles, 
protective clothing and surfaces within hospital wards4. Transmission from fomites within healthcare settings has 
led to C. difficile overtaking methicillin resistant Staphylococcus aureus (MRSA) as the leading cause of hospital 
acquired infection globally5.
Symptoms of C. difficile infection (CDI) can range from mild to severe diarrhoea to pseudomembranous 
colitis, toxic megacolon, colonic perforation and death6,7. Certain factors increase the risk of CDI such as use 
of broad-spectrum antibiotics8, old age and hospitalization9. When an individual is diagnosed with a toxigenic 
C. difficile infection they are isolated, when possible, from other patients and facilities in an attempt to curb trans-
mission via spores to other individuals in the hospital, particularly those on antibiotics10.
More than three hundred different ribotypes of C. difficile have been detected in humans11, with prevalence 
of different ribotypes varying between countries, and regionally12. Strains of C. difficile can be characterised into 
five genetically distinct clades, all of which contain toxigenic strains capable of causing infection13,14. In Northern 
Ireland the most common ribotype found to be causing infection in humans is ribotype 07815.
For decontamination of clinical areas, various methods are applied, including chemical disinfection, spo-
ricidal fumigants and antimicrobial surfaces16. Many studies have shown that commonly used methods for 
hospital cleaning are not effective for the decontamination of C. difficile spores17, including alcohol based hand 
sanitation18. Chlorine based cleaning reagents, with a minimum of 1000ppm available chlorine, are capable of 
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decontaminating fomites harbouring C. difficile spores19. However, UK COSHH regulations restrict occupational 
exposure to chlorine to 0.5ppm20. Difficil-S® (Clinimax Ltd, UK) is a chlorine dioxide based sporicidal product 
which has found application in a number of healthcare settings, C. difficile eradication efficiency is nevertheless 
similar to that of standard National Health Service approved cleaning procedures21.
Sporicidal fumigation using gaseous hydrogen peroxide and chlorine dioxide may also be an effective strategy 
for C. difficile control22. Gaseous decontamination however requires rooms to be sealed for effective treatment, 
and the pre-cleansing of all surfaces. The effectiveness and commercial viability of such gas based decontamina-
tion strategies have yet to be fully established22. Furthermore when using gaseous chlorine dioxide, additional 
precautions must be taken, since it is explosive at high concentrations. Copper surfaces have also been found 
to reduce the viability of, but not fully eradicate, C. difficile spores23. Due to expense and efficacy, copper based 
systems can only be considered as part of a wider decontamination scheme24. There is therefore a clear need for 
robust alterative decontamination strategies for application within a clinical setting.
Atmospheric pressure non-thermal plasmas are attracting attention within the medical and life sciences 
fields as potential treatments for skin conditions, cancer, chronic infected wounds and decontamination of biotic 
and abiotic surfaces25. Atmospheric plasmas can be described as a partially ionised gas, which can produce a 
low-temperature plasma capable of propagating in air. This allows treatment and exposure of heat sensitive items 
at ambient pressure, without the necessity for large, bulky equipment, which is typically required for low-pressure 
systems. These low-pressure plasma systems have been employed within the medical setting for sterilization 
applications since the early 1970’s, although they could be more appropriately termed ‘plasma assisted’, combin-
ing the production of a plasma with addition of gaseous hydrogen peroxide26. In contrast plasma generated at 
atmospheric pressure by gases such as argon and helium can provide rapid on-site decontamination and could 
potentially be used for high-level disinfection in clinical environments.
This research employed an in-house designed kHz-driven dielectric barrier discharge plasma jet (Fig. 1) that 
has previously been shown to successfully exert rapid and significant antimicrobial activity against microorgan-
isms in both planktonic and biofilm phenotypes27,28. In this study the sporicidal activity of the in-house system 
was evaluated, for the first time. Non-thermal plasma exposure against C. difficile spores was assessed and factors 
affecting sporicidal efficacy, including percentage of oxygen in the helium carrier gas admixture, and the effect of 
plasma treatment on spores from varying C. difficile strains (representing the five evolutionary C. difficile clades) 
was investigated. Inactivation of ribotype 078, the most prevalent clinical isolate in Northern Ireland, was further 
assessed with respect to surface decontamination, pH, and hydrogen peroxide concentration.
Results
Optimum oxygen concentration for deactivation of C. difficile spores with He/O2 plasma 
jet. In order to ascertain how the addition of oxygen affected plasma sporicidal activity, an oxygen titration 
was carried out to confirm the concentration of oxygen that would provide optimum spore inactivation. Between 
0–0.5% oxygen gas added increased plasma-induced sporicidal activity (p = 0.005), with no further decrease 
noted after 0.5% (Fig. 2).
Susceptibility of different C. difficile clades to non-thermal plasma exposure. Representative 
strains from the five evolutionary clades of C. difficile were exposed to cold plasma in quintuplicate: TL178 (clade 1, 
Figure 1. (A) Image of plasma treating a well of a 96 well plate. (B) Schematic diagram of plasma device.
www.nature.com/scientificreports/
3Scientific RepoRts | 7:41814 | DOI: 10.1038/srep41814
ribotype 002); R20291 (clade 2, epidemic ribotype 027); CD305 (clade 3, ribotype 023); CF5 (clade 4, ribotype 
017) and M120 (clade 5, ribotype 078). Clade 1 and 5 isolates appear to be the most susceptible (Fig. 3A). After 
plasma exposure for 30 seconds the viable spores recovered for M120, TL178 and CD305 were 7%, 13% and 
18% respectively, compared with CF5 and R20291 which had 40% and 52% viable spores remaining. All clades 
Figure 2. Survival of C. difficile spores after 60 seconds plasma exposure using varying oxygen 
concentrations within a helium plasma alongside untreated spores. Each bar represents the average of five 
replicates with error bars showing the standard error.
Figure 3. (A) Comparison of clade-specific tolerance to atmospheric pressure plasma treatment; 
R20291( ), CF5 ( ), CD305 ( ), TL178 ( ) and M120 ( ). Spores were dried onto wells of a 
96 well plate and treated with a helium/oxygen (0.5%) plasma plume. Each bar represent the average of five 
replicates, error bars represent the standard error; (B) Effect of He/O2 plasma on purified and non-purified 
spores from most and least resistant strains, R20291 and M120. The plasma jet was used to treat purified spores 
dried onto microtitre plate wells from R20291 ( ) and M120 ( ) and non- purified spores dried onto 
microtitre plate wells from R20291 ( ) and M120 ( ). Each bar represents the average of three 
replicates, error bars represent the standard error.
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displayed approximately a 3 log reduction after plasma treatment for 5 minutes. The D value for each represent-
ative strain was different, with ribotype 027 (R20291, clade 2) proving to be the most resistant to the treatment 
(Table 1).
To exclude the possibility that cell debris in the spore preparations might influence susceptibility to plasma, 
spores from the most and least susceptible strains (M120 and R20291 respectively) were purified according to 
the method of Tavares et al.29 and subjected to plasma exposure (Fig. 3B). Cold plasma inactivation results using 
purified spore preparations were similar for both strains to those results obtained using the non-purified spore 
preparation (Fig. 3B). A D value of 0.4 minutes was seen for both purified and crude M120 spore suspensions, 
and with R20291 the D value for purified spores was 3.2 minutes compared to 3.4 minutes for non-purified spores.
The effect of different environmental conditions on spore viability of strain M120. Deactivation 
of C. difficile ribotype 078 spores on surfaces was investigated under three different environmental conditions: 
spores dried onto the surface of microtitre plate wells; spores dried onto the surface in the presence of organic 
matter (0.03% BSA) and spores suspended in sterile distilled H2O. Spores dried onto the surface of the microtitre 
plate without organic matter appeared to be the most susceptible to plasma treatment with spore concentrations 
decreasing to 2.8 ± 1.2 spores per well after 1 min treatment (Fig. 4). With the spores in suspension, the num-
bers declined less rapidly but eventually reached an average of 25.4 ± 5.4 spores/100 μ l after 5 minutes of plasma 
exposure, a 3 log reduction in spore count. For spores treated in the presence of BSA, spore counts declined to an 
average of 63.2 ± 16.6 spores per well after 5 minutes.
D values for plasma application in the different environments were calculated. Air-dried spores in wells were 
the most susceptible with a D value of 0.4 minutes. For both the spores in the presence of BSA and suspended in 
sterile H2O, the D values obtained were higher, being 1.7 and 1.8 minutes respectively.
The effect of pH and H2O2 on spore viability of strain M120. Increasing plasma exposure time 
decreases water pH: After 2 and 5 minutes plasma exposure, pH decreases to pH 4 and pH 2 respectively (Fig. 5). 
After 2 minutes plasma exposure there was a significant drop in the number of spores recovered (p = 1.06 × 10−9). 
No further significant decrease in spore recovery was observed after 5 minutes treatment (p = 0.637; Fig. 5). In 
non-plasma treated, pH altered controls, exposure of spores to pH 4 for 2 minutes did not result in the same 
reduction in spore viability as with a 2 minute plasma exposure (p = 7.79 × 10−7); 12% of spores were recov-
ered after plasma treatment compared to 41% in the pH4.0 amended cultures. Similarly in non-plasma treated 
pH 2.0 controls spore viability was significantly higher than in the corresponding plasma treated cultures 
(p = 2.37 × 10−5) (Fig. 6).
In addition to pH change, plasma treatment of water for 5 minutes results in the production of approximately 
0.7 mM H2O2 (Fig. 5). Non-plasma treated pH 2 control cultures supplemented with H2O2 (0.7 mM) reduced 
Strain (Ribotype, Clade) D value (minutes)
M120 (078, 5) 0.4
CD305 (023, 3) 1.9
TL178 (002, 1) 2.3
CF5 (017, 4) 3.2
R20291 (027, 2) 3.4
Table 1.  Summary of D values for plasma treatment of each representative strain of the five clades.
Figure 4. Effect of He/O2 plasma on C. difficile M120 spores under different conditions. The plasma jet was 
used to treat spores dried onto microtitre plate wells ( ), spores dried in the presence of 0.03% BSA ( ), 
and spores suspended in sterile distilled H2O ( ). Gas-only controls, both on dry spores (small dash) and in 
suspension (large dash), are also displayed. Each point shows the average of five replicates along with the 
associated standard error.
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spore viability less than the cognate 5 minute plasma treatment (p = 1.03 × 10−9; Fig. 6). There was no significant 
decrease in spore viability between pH 2 controls and those pH 2.0 controls augmented with H2O2 (0.7 mM). 
After exposure to plasma for 5 minutes, only 3% of spores were recovered. In non-plasma treated controls, after 
a 5 minute treatment at pH 2, or at pH 2.0 in the presence of H2O2 (0.7 mM), spore recoveries were 43% and 52% 
respectively (Fig. 6).
Discussion
Previous studies have demonstrated the sporicidal effect of plasma produced in air with surface discharge30 and 
a compressed air jet31 to decontaminate C. difficile spores. The ability of a helium/oxygen atmospheric pressure 
plasma jet to deactivate C. difficile spores has also been demonstrated32, whilst a separate study found helium/
oxygen plasma ineffective against C. difficile spores33. This study reinforces the fact that helium/oxygen plasma 
can be used for decontamination of C. difficile spores and describes for the first time how factors such as oxygen 
addition to the plasma, strain variation across the five genetic clades of C. difficile and environmental conditions 
can affect spore survival.
There was a noticeable increase in sporicidal activity with the increase in oxygen up to 0.5% with a plateau 
from the addition of 0.75% and 1% oxygen. The role of oxygen concentration in plasma-mediated sporicidal activ-
ity has been previously noted by Hong et al.34, whereby increasing oxygen concentration increased plasma activity 
against Bacillus subtilis endospores. That 0.5% oxygen added to plasma feed gas provided the greatest reduction 
Figure 5. Effect of plasma exposure on 100 μ l of water on pH ( ) and the production of hydrogen 
peroxide ( ). Each point represents the mean of three replicates with standard error.
Figure 6. The effect of pH, hydrogen peroxide concenration and the corresponding plasma treatment of 
5 minutes on viable spore count. Each bar represents the average of nine replicates with error bars showing the 
standard error.
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would suggest the production of a particular species in the gas phase plasma may be responsible for plasma’s 
activity against C. difficile spores. Increasing oxygen past 0.5% may lead to a destabilisation of the plasma35.
The representative Clade 5/ribotype 078 strain M120 was the most susceptible to plasma exposure and 
recorded the shortest decimal reduction time for viable spore count (0.4 minutes). Ribotype 078 is the most 
common ribotype found infecting patients in Northern Ireland, and has been shown to be particularly virulent, 
with one study reporting 25% mortality within 14 days amongst infected individuals compared with 20% for 027 
infections36.
Notably, the ribotype 027 isolate, R20291, showed an eight-fold increase in the D value and the greatest 
resistance to plasma treatment after 5 minutes exposure. The fact that C. difficile spores exhibit clade dependent 
tolerance to inactivation by plasma is an important observation. C. difficile ribotypes vary with respect to viru-
lence, sporulation levels and toxin production rates37,38. Ribotype 027 appears to be particularly virulent, and has 
become a global epidemic strain39 causing numerous large outbreaks with high mortality. Conversely, there is 
evidence to suggest that not all strains of this ribotype can be categorised as highly virulent and that the clinical 
outcome is difficult to predict using ribotype alone40. Some studies have been carried out into the composition 
of the spore coat for C. difficile, in particular the role of the CotA protein, in spore resistance to environmental 
factors, such as heat and ethanol resistance41. Variation in spore coat structure may explain observed differences 
in susceptibility to cold plasma between strains.
The influence of different environmental conditions on plasma surface decontamination was investigated. 
C. difficile M120 spores were exposed to plasma under three different conditions: dried onto sterile plastic wells, 
dried onto sterile plastic wells in the presence of 0.03% BSA (replicating organic matter) and spores in aqueous 
suspension (replicating a wet/damp environment). A clean dry environment provided the greatest reduction 
in spores and shortest D value (0.4 minutes), compared to dried albumin (D value = 1.7 minutes) and C. dif-
ficile spores suspended in water (D value = 1.8 minutes). The observation that organic matter increases spore 
survival to plasma exposure has previously been reported by Klampf et al., 2014, where they assessed a surface 
micro-discharge against C. difficile endospores in the presence of 0.03% albumin30. The presence of organic mat-
ter is known to attenuate the efficacy of medical device disinfection42 and is an important consideration when 
assessing plasma for high level disinfection. In this scenario it is plausible that the BSA is providing a barrier 
between plasma exposure and the spores, or through sequestration of active species. That direct plasma treatment 
in a dry environment resulted in the greatest inactivation of spores suggests that surfaces and items for plasma 
disinfection would need to be clean and dry for effective decontamination. Further studies into factors that may 
affect spore inactivation would be justified, particularly with respect to spore age.
Comparing plasma exposures of spores in a dry and aqueous environment presents two differing plasma 
chemistries. In the dry environment effcacy would be highly dependent on the plasma’s gas phase reactive species 
and the electrostatic interaction of the plasma and the spores directly. In an aqueous environment the sporicidal 
activity would be dependent on either the generation of reactive species within the water, the reduction in pH of 
plasma treated water or a combination of both. With respect to the generation of reactive components, plasma 
treatment leads to the formation of both short lived (e.g. OH and 1O2), and long lived (hydrogen peroxide26) 
reactive species: Sun et al.43 have previously demonstrated that the former have half-lives in the range of 10−6–
10−9 seconds (and would be both diluted and quenched upon plating of spores on solid media). Plasma-mediated 
hydrogen peroxide induced oxidative stress is therefore the primary hypothesised mechanism for the bactericidal 
nature of plasma44.
The effect of pH and hydrogen peroxide alone on sporicidal activity, in the absence of plasma treatment 
(Fig. 6), was investigated. Whilst pH appears to play a role in plasma-mediated spore inactivation, pH effects 
alone cannot fully explain the sporocidal activity of plasma. As inclusion of hydrogen peroxide into the pH 2 
spore suspensions did not increase spore inactivation (in the absence of plasma), carry-over of hydrogen peroxide 
into the germination media - which would destroy C. difficile vegetative cells (i.e. through an indirect or delayed 
effect on viability) - seems unlikely. Further studies are thus required to dissect the mechanisms involved in 
plasma mediated sporicidal activity.
Low temperature plasmas are increasingly being utilized in clinical settings24,45,46 e.g. the portable kINPen sys-
tem which was CE-certified in 2013. Our jet system has also previously been modified for hand-held use within 
the clinical environment. It is currently being assessed as a tool for the high level disinfection of niche areas, 
particularly the cantilever of duodenoscopes which are not amenable to traditional disinfectant methods47. This 
study therefore provides further evidence as to the potential of our cold plasma system for high level disinfection, 
in this case against C. difficile, a globally important spore-forming nosocomial pathogen.
Materials and Methods
Preparation of spore suspensions. Spore suspensions of representative ribotypes from the five C. diffi-
cile clades were prepared: - TL178 (Clade 1, Ribotype 002); R20291 (Clade 2, Ribotype 027); CD305 (Clade 3, 
Ribotype 023); CF5 (Clade 4, Ribotype 017) and M120 (Clade 5, Ribotype 078). All isolates were obtained from 
the Kelvin Laboratories at the Royal Victoria Hospital, Belfast. Brazier’s agar plates (OXOID, UK) were inocu-
lated with each strain and incubated anaerobically (N2/CO2/H2) at 37 °C for 48 hours in an anaerobic chamber 
(Don Whitley Scientific). Colonies were harvested from the plates, resuspended in 5 ml sterile saline solution 
(Sigma-Aldrich Company Ltd., Dorset, UK) and subjected to alcohol shock (5 ml of absolute ethanol added to 
5 ml suspension) for 1 hour to kill vegetative cells, in accordance with the spore culture method of UK Standards 
for Microbiology Investigations48. Suspensions were centrifuged at 3000 × g for 4 minutes, and washed once in 
5 ml of sterile saline (0.9% w/v). Pellets were resuspended in 5 ml of saline (0.9% w/v), with Tween20 (0.05% v/v) 
(Sigma-Aldrich Company Ltd.).
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Spore purification. Spore suspensions of R20291 and M120 were subject to further purification using the 
method of Tavares et al.29 giving spore preparations of >90% purity. Spore suspensions were centrifuged for 
10 minutes at 10,000 × g at 4 °C and resuspended in 50 mM Tris-HCl (Sigma-Aldrich Company Ltd.), at pH 7.2, 
containing 50 μ g/ml of lysozyme (Sigma-Aldrich Company Ltd.). After 1 hour incubation at 37 °C, the suspen-
sions were centrifuged for 10 minutes at 10,000 × g and washed with 5 ml sterile distilled water. Suspensions were 
centrifuged again using aforementioned conditions and pellets were resuspended in 0.05% SDS solution. Spores 
were washed three times in sterile distilled water and final pellets were resuspended in 5 ml sterile distilled water. 
Spore purity was confirmed via phase microscopy.
Preparation of test plate. For dry spores. Spore suspensions were centrifuged at 3000 × g for 4 minutes 
and spores resuspended in 70% ethanol. 100 μ l aliquots of this ethanolic spore suspension were dispensed, with 
continuous mixing, into wells of a 96-well NuncTM microtitre plate (Sigma-Aldrich Company Ltd.) and left to air 
dry overnight in a fume cabinet (Holliday Fielding Hocking Ltd.).
For spores in suspension. Spore suspensions were centrifuged at 3000 × g for 4 minutes and resuspended in ster-
ile dH2O. 100 μ l aliquots of this aqueous spore suspension were dispensed, with continuous mixing, into wells of 
a 96-well NuncTM microtitre plate.
For spores in presence of organic matter. Spore suspensions were centrifuged at 3000 × g for 4 minutes and resus-
pended in an aqueous Bovine Serum Albumin, BSA, (Sigma Aldrich Corp.) solution at 0.03% (w/v)30. 100 μ l 
aliquots of this BSA supplemented spore suspension were dispensed, with continuous mixing, into wells of a 
96-well NuncTM microtitre plate and left to air dry overnight in a fume cabinet (Holliday Fielding Hocking Ltd.).
Each well contained 1300 ± 150 spores as determined by viable spore counts for each environmental condi-
tion. Each condition and exposure time was replicated five times.
Plasma source and experimental plasma treatment of spores. The atmospheric pressure kHz 
plasma source used in this study has previously been described in detail28,49,50. Developed within the School of 
Mathematics and Physics Queen’s University Belfast, the jet consists of two copper electrodes encircling a quartz 
tube with an inner diameter of 4 mm and outer diameter of 6 mm. The powered electrode is 20 mm from the 
nozzle end and the grounded electrode is 25 mm from the powered. Standard operating conditions of 6 kV and 
20 kHz were used to produce a helium/oxygen (0.5%) plasma with a gas flow rate of 2 standard litre per minute 
(SLM). Samples were treated within wells of a 96 well plate at a distance of 7 mm from the end of the quartz tube 
to the top of the plate as shown in the experimental schematic (Fig. 1). The top of the 96 well plate was at a mini-
mum distance of 27 mm from the powered electrode.
For each treatment condition and treatment time, five replicates were exposed to the plume of the plasma jet 
for 0, 0.5, 1, 2, 3 and 5 minutes within the wells of a 96 well plate. Helium/oxygen (0.5%) gas at a flow rate of 2 
SLM was used to treat dried spores for 5 minutes ensuring that gas flow alone did not affect spore counts within 
the wells (gas-only controls).
The time required to achieve a 1 log reduction in viable spore count (D, minutes) was calculated for each 
experimental condition.
After plasma exposure experiments, Brazier’s agar plates (OXOID, UK) were inoculated with the 100 μ l spore 
suspensions (either taken directly from wells for aqueous spore suspensions, or after resuspension of dry spores 
using 100 μ l of sterile distilled H2O) and incubated at 37 °C in an anaerobic chamber for 48 hours. After incuba-
tion viable spore counts were obtained by counting the colonies formed on the agar plate.
Measurement of hydrogen peroxide and pH of plasma treated water. Unless otherwise specified, 
reagents and chemicals were supplied by Sigma-Aldrich. Titanium sulphate was used to colorimetrically deter-
mine the concentration of hydrogen peroxide produced in plasma treated water51,52. 100 μ l of deionised water 
was exposed to the plasma effluent for the same time points as for the spore exposure in triplicate. After expo-
sure 10 μ l was added to 90 μ l of water in wells of a Nunc-96 well plate (Fisher Scientific UK Ltd. Loughborough, 
UK) followed immediately by the addition of 10 μ l of a 60 mM sodium azide solution to stabilize hydrogen per-
oxide in acidic conditions. 50 μ l of titanium sulphate was added forming the yellow peroxotitanium complex. 
Absorbance was read at 400 nm using a microplate reader. (BioTek EL808; BioTek Instruments Ltd. Potton, UK). 
H2O2 concentrations were calculated from a standard curve. pH measurements of plasma treated water were con-
ducted in triplicate using a calibrated Minitrode combination electrode pH meter (Hamilton Company, Bonaduz, 
Switzerland).
Effect of pH and Hydrogen Peroxide on spore viability of M120. The effect of pH and hydrogen 
peroxide (H2O2) production on spore viability was investigated as they represent known conditions induced by 
plasma exposure51.
Solutions of sterile distilled water at pH 2, 4 and 7 were prepared, the pH was adjusted using 0.1 M hydrochlo-
ric acid (HCl) alongside a 700 μ M solution of hydrogen peroxide at pH 2.
Aliquots of C. difficile M120 spore suspension were centrifuged at 3000 × g for 4 minutes and spores resus-
pended in the appropriate test solutions. Spores were incubated at each pH for times equivalent to cold plasma 
treated water (Fig. 5) to control for sporicidal effects due to low pH and H2O2 production alone.
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